House Endeavor to Accelerate a Legislative Transformation of Healthcare Act or the HEALTH ActThis resolution establishes the Committee on Health, a standing committee of the House of Representatives, and specifies the subjects within its jurisdiction. The Committee on Health is responsible for all legislation and other matters relating to biomedical research and development (including the Food and Drug Administration); health, health facilities, and health care supported by general revenues (except veterans’ hospitals, medical care, and treatment); and public health and quarantine (including the Centers for Disease Control and Prevention). The resolution also removes these topics from the jurisdiction of the Committee on Education and the Workforce and the Committee on Energy and Commerce.
Impact
The formation of the Committee on Health signifies a strategic shift in how healthcare legislation is handled within the House. By consolidating health-related issues under a dedicated committee, the bill seeks to streamline discussions and decision-making processes, thus allowing for more focused and specialized attention to healthcare matters. As a result, this could lead to more coherent and thorough health policies being developed and advanced, addressing the specific needs of health and biomedical research areas.
Summary
HR10, known as the Healthcare Endeavor to Accelerate a Legislative Transformation Act, proposes the establishment of a new standing committee in the House of Representatives specifically focused on health-related matters. This resolution acts to reorganize existing legislative responsibilities concerning health by clearly delineating the scope of this new committee. It will oversee biomedical research and development, health facilities, and public health initiatives, except for those specifically related to veterans. The creation of this committee is aimed at enhancing oversight and improving legislative efficiency concerning healthcare legislation.
Contention
Notable points of contention surrounding HR10 may arise concerning the potential impacts on existing committees that currently manage health issues. Critics might express concerns that reassigning health matters could dilute the attention they receive from other committees and result in inadequately addressed areas of healthcare legislation that intersect with education, commerce, and workforce concerns. Furthermore, the delineation of responsibilities between the new health committee and existing committees may face scrutiny, with fears that the consolidation of authority could potentially lead to oversights in public health advocacy.
Expressing the sense of Congress that the United States is committed to ensuring a safe and healthy climate for future generations, and thus to restoring the climate.
Preventing Vigilante Stalking that Stops Women's Access to Healthcare and Abortion Rights Act of 2022 This bill increases the maximum prison term for a stalking offense, if the offense is committed with the intent to obtain an individual's health care information or prevent an individual's health care decisions.
Triple-Negative Breast Cancer Research and Education Act of 2023 This bill requires research and education activities related to triple-negative breast cancer. The cells of these breast cancers are negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so they do not respond to hormonal therapy medicines or medicines that target the HER2 protein receptors. Specifically, the National Institutes of Health must conduct and support research into the disease. Additionally, the Centers for Disease Control and Prevention and the Health Resources and Services Administration must develop information about triple-negative breast cancer, including information regarding the elevated risk for minority women, for the public and for health care providers.
To amend the Toxic Substances Control Act to authorize grants for toxic substances remediation in schools, to reauthorize healthy high-performance schools, and for other purposes.